Literature DB >> 21277761

Epidemiologic perspective on immune-surveillance in cancer.

Daniel W Cramer1, Olivera J Finn.   

Abstract

Common 'themes' in epidemiology related to cancer risk beg a comprehensive mechanistic explanation. As people age, risk for cancer increases. Obesity and smoking increase the risk for many types of cancer. History of febrile childhood diseases lowers the risk for melanomas, leukemias, non-Hodgkin's lymphoma (NHL), and ovarian cancer. Increasing number of ovulatory cycles uninterrupted by pregnancies correlate positively with breast, endometrial, and ovarian cancer risk while pregnancies and breastfeeding lower the risk for these cancers as well as cancers of the colon, lung, pancreas, and NHL. Chronic inflammatory events such as endometriosis or mucosal exposure to talc increase the risk for several types of cancer. Mechanisms so far considered are site specific and do not explain multiple associations. We propose that most of these events affect cancer immunosurveillance by changing the balance between an effective immune response and immune tolerance of an emerging cancer. We review recently published data that suggest that immune mechanisms underlie most of these observed epidemiologic associations with cancer risk.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21277761      PMCID: PMC3073666          DOI: 10.1016/j.coi.2011.01.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  70 in total

1.  Hallmark features of immunosenescence are absent in familial longevity.

Authors:  Evelyna Derhovanessian; Andrea B Maier; Robert Beck; Gerhard Jahn; Karin Hähnel; P Eline Slagboom; Anton J M de Craen; Rudi G J Westendorp; Graham Pawelec
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

2.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy women.

Authors:  A B Erbağci; N Yilmaz; I Kutlar
Journal:  Dis Markers       Date:  1999-12       Impact factor: 3.434

4.  An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.

Authors:  F M Brichory; D E Misek; A M Yim; M C Krause; T J Giordano; D G Beer; S M Hanash
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients.

Authors:  B Jezersek; Z Rudolf; S Novakovic
Journal:  Oncol Rep       Date:  2001 Jan-Feb       Impact factor: 3.906

6.  Delayed infection, family size and malignant lymphomas.

Authors:  P Vineis; L Miligi; P Crosignani; A Fontana; G Masala; O Nanni; V Ramazzotti; S Rodella; E Stagnaro; R Tumino; C Viganò; C Vindigni; A S Costantini
Journal:  J Epidemiol Community Health       Date:  2000-12       Impact factor: 3.710

7.  Mumps and ovarian cancer: modern interpretation of an historic association.

Authors:  Daniel W Cramer; Allison F Vitonis; Simone P Pinheiro; John R McKolanis; Raina N Fichorova; Kevin E Brown; Todd F Hatchette; Olivera J Finn
Journal:  Cancer Causes Control       Date:  2010-06-18       Impact factor: 2.506

8.  Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.

Authors:  J R Bosscher; C Gerçel-Taylor; C S Watkins; D D Taylor
Journal:  Gynecol Oncol       Date:  2001-05       Impact factor: 5.482

9.  Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors.

Authors:  Rikke Sick Andersen; Rikke Bæk Sørensen; Cathrin Ritter; Inge Marie Svane; Jürgen C Becker; Per thor Straten; Mads Hald Andersen
Journal:  Cancer Immunol Immunother       Date:  2010-10-28       Impact factor: 6.968

10.  Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.

Authors:  H Kao; J A Marto; T K Hoffmann; J Shabanowitz; S D Finkelstein; T L Whiteside; D F Hunt; O J Finn
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  41 in total

1.  Immune aging and challenges for immune protection of the graying population.

Authors:  Abbe N Vallejo
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

2.  Ovarian cancer risk associated with inherited inflammation-related variants.

Authors:  Kristin L White; Joellen M Schildkraut; Rachel T Palmieri; Edwin S Iversen; Andrew Berchuck; Robert A Vierkant; David N Rider; Bridget Charbonneau; Mine S Cicek; Rebecca Sutphen; Michael J Birrer; Paul P D Pharoah; Honglin Song; Jonathan Tyrer; Simon A Gayther; Susan J Ramus; Nicolas Wentzensen; Hannah P Yang; Montserrat Garcia-Closas; Catherine M Phelan; Julie M Cunningham; Brooke L Fridley; Thomas A Sellers; Ellen L Goode
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

Review 3.  A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.

Authors:  Olivera J Finn
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

4.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

Review 5.  Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance.

Authors:  Olivera J Finn
Journal:  Exp Mol Pathol       Date:  2012-10-23       Impact factor: 3.362

6.  Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.

Authors:  Camille Jacqueline; Amanda Lee; Nolan Frey; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2020-05-28       Impact factor: 11.151

7.  Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).

Authors:  Joellen M Schildkraut; Sarah E Abbott; Anthony J Alberg; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Lauren C Peres; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Fabian Camacho; Frances Wang; Patricia G Moorman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-12       Impact factor: 4.254

8.  The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:  Hari Sankaran; Heather E Danysh; Michael E Scheurer; M Fatih Okcu; Stephen X Skapek; Douglas S Hawkins; Logan G Spector; Erik B Erhardt; Seymour Grufferman; Philip J Lupo
Journal:  Pediatr Blood Cancer       Date:  2016-05-19       Impact factor: 3.167

9.  MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Authors:  Takashi Kimura; John R McKolanis; Lynda A Dzubinski; Kazi Islam; Douglas M Potter; Andres M Salazar; Robert E Schoen; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

Review 10.  Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.

Authors:  Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2014-08       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.